Partnering Overview

High-Complexity CLIA Laboratory Testing
and Clinical Test Development

Applications: COVID-19, inflammation, immune response and other disease pathways

ProterixBio operates a high-complexity, CLIA-certified clinical testing laboratory. We have expertise in the development and validation of quantitative clinical assays for inflammation, immune response and a variety of other disease pathways. ProterixBio has extensive experience with COVID-19, as well as chronic obstructive pulmonary disease (COPD) and other chronic diseases. We also have expertise in the integration of remote sample collection methods with clinical testing, covering a variety of devices and sample types.

If you are interested in a CLIA testing partner and/or a clinical test development partner, please contact us.

 

 

Learn more about partnering with ProterixBio: